Pharmacology Effectiveness of streptokinase in Acute Miocardial Infarction Abstract: Acute myocardial infarction can be treated using streptokinase. Streptokinase is derived from Streptococci. This Enzyme is a protein that binds to the plasmingoen and induces the thrombolysis…
Download full paperFile format: .doc, available for editing
Download file to see previous pages
The administration of aspirin and heparin before the treatment will increase the survival rate. Introduction: Acute myocardial infraction is the breakdown of the heart muscles due to the lack of oxygen supply. The shortage in oxygen supply is caused by the collection of lipids at the heart muscles. This creates a block in the blood vessels resulting in ischemia and if left untreated it results in infraction of the myocardial cells. The risk factors of acute myocardial infarction (AMI) are cardiovascular disease, tobacco smoking, older age, kidney diseases, blood pressure, excessive alcohol consumption and obesity. Streptokinase is one of the first thrombolytic agent to be used for the treatment of Acute myocardial infarction. Streptokinase was discovered in the year 1933 by Dr. William Smith Tillett. The use of Streptokinase for the treatment of acute myocardial infarction started in the year 1947 when Sol Sherry identified the potential of streptokinase. (Sikri and Bardia, 2007).The clinical trials using streptokinase started thereafter. They concluded that streptokinase can be used to treat hemothorax, purulent and sanguineous pleural exudations, fibrinous and tuberculosis meningitis. (Sikri and Bardia, 2007).The difficulties in purifying the protein streptokinase led to the delay in the intravenous use. The intravenous use of streptokinase was started in the year 1952. This proved to be a promising approach. ...
Streptokinase binds to the circulating plasminogen and forms a complex. This complex activates the plasminogen through a three step mechanism. If fibrin is present, then the streptokinase – plasmin complex forming capacity gets increased and thus lyses the clots. (Becker, 1997). After infusion of the clot, the streptokinase spreads through the plasma. There are two phases of streptokinase clearance. The half life of first phase streptokinase is 11-17 minutes and that of the second phase is 85 minutes. The current recommended dose level of streptokinase is 1.5 million units for 30- 60 minutes. (Becker, 1997). The main drawback of streptokinase is that it is antigenic. The administration of streptokinase produces antibodies in the blood. The antibodies formed may neutralize the drug. (Becker, 1997). Development: After the discovery of Streptokinase in the year 1933, the mechanisms of action of streptokinase in humans were determined. In 1959, Ruegsegger discovered the intracoronary clots. Many clinical trials were conducted at this time. There was a small risk of allergy. Many investigators considered this to be the plausible option for the treatment of acute myocardial infraction. In the year 1985 many small trials were conducted to standardize the protocol for streptokinase but no trial produced positive result. Finally they concluded that when the drug was administered for 1.5 to 3 hours, they were able to receive reperfusion rate of 90%. (Sikri and Bardia, 2007). GISSI Trial: Gruppo Italiano per la Sperimentazione della Streptochinasi nell'Infarto Miocardico ( GISSI) trial was conducted as the large scale trial. 11806 patients were enrolled in the study for a period of 17 months in 176 coronary heart care centre. New patients were recruited at a rate of
...Download file to see next pagesRead More
Cite this document
(“Pharmacology Effectiveness of streptokinase in Acute Miocardial Research Paper”, n.d.)
Retrieved from https://studentshare.org/nursing/1435748-pharmacology-effectiveness-of-streptokinase-in
(Pharmacology Effectiveness of Streptokinase in Acute Miocardial Research Paper)
“Pharmacology Effectiveness of Streptokinase in Acute Miocardial Research Paper”, n.d. https://studentshare.org/nursing/1435748-pharmacology-effectiveness-of-streptokinase-in.
The author explains that there are many predisposing factors to the higher number of MI cases. Some of these factors can be controlled while others cannot. These factors are; age, gender, positive family history of MI, high blood pressure, obesity, high levels of cholesterol, lack of physical activity, diabetes, stress, hypertension.
Design A combination of both quantitative and qualitative approaches using analysis of synthesized primary and secondary data from clinical trials and cardiac/coronary research. Setting The setting of the study will be health institutions emergency departments.
Plagues are deposits of cholesterol over the wall of the blood vessels. They are formed due to gradual deposition over a period of time (Alpert et al, 2000). Sometimes, plaques rupture and can result in blood clots within blood vessels. These clots block the blood vessel and result in sudden decrease of blood supply to the myocardium.
An imbalance in this predisposes the heart muscle to ischemia, which means reduced blood flow. The tissue death as a result of ischemia occurs because of two reasons, reduced oxygen supply and the decreased delivery of nutrients, both of which are brought in by the flow of blood though the heart muscle.
There are a wide variety of pharmaceuticals that treat illnesses from cancer to hypertension. Some medications were created in order to help regulate physiological conditions and some were created in order to help decrease pain sensitivity. There is a specific field of medicine dealing with neuropsychopharmacology called psychiatry.
These factors are; age, gender, positive family history of MI, high blood pressure, obesity, high levels of cholesterol, lack of physical activity, diabetes, stress, hypertension, increased serum triglycerides, excessive intake of saturated fats, salt and carbohydrates.
Various diagnostic features aid in determining MI; these include sustaining regional ST rise through ECG, cardiac enzyme studies etc. In developed nations like the United States, deaths from heart disease are more abundant than the mortality from cancer. One in five deaths in the United States is due to coronary heart attacks.
There are lesser causes though, among which are viral infections, surgery done to the pancreas, constant bile duct surgery, medications, and traumatic injury. Some possible causes are hereditary in nature , hypertriglyceri-demia,
The objective of the study is to focus over the problem and treatment process of pneumonia. The study further aims to analyze the factors causing pneumonia and discusses its impact over the health of people. Furthermore, the paper gives a brief description of entire process associated with pneumonia treatment.
15 Pages(3750 words)Research Paper
GOT A TRICKY QUESTION? RECEIVE AN ANSWER FROM STUDENTS LIKE YOU!
Save Your Time for More Important Things
Let us write or edit the research paper on your topic
"Pharmacology Effectiveness of streptokinase in Acute Miocardial Infarction"
with a personal 20% discount.